跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
MAPOLI 25MG/ ML SOLUCION ORAL EFG
Approved
STANDARD
MAPOLI 25MG/ ML SOLUCION ORAL EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 16, 2022
Approval ID
247d68d0960bc4c9
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
247d68d0960bc4c9
Drug Cima Aemps Name
MAPOLI 25MG/ ML SOLUCION ORAL EFG
Register Number
86637
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Glenmark Farmaceutica S.L.U
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2022-03-16
Dosage Form
SOLUCIÓN ORAL
Dose
25 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
27,23 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 16, 2022
Approval ID
247d68d0960bc4c9
Type
Standard
Back to CIMA-AEMPS Approvals
MAPOLI 25MG/ ML SOLUCION ORAL EFG - CIMA-AEMPS Drug Approval Details